Press Releases
- September 2007
Clinical Data Inc. launches Algynomics' genetic Pain Research Panel:
Press Release.
- August 2007
Dr. Samuel McLean joins Algynomics as Chief Medical Officer and
will coordinate the development of therapeutic trials.
- July 2007
Algynomics and Pfizer Inc. enter into a research collaboration in
pain genetics.
- February 2007
Algynomics and Orthogen Inc. establish an alliance in individualized
orthopedic medicine:
Press Release.
- December 2006
Scientific founders publish a newly discovered genetic mechanism that partially explains chronic pain conditions in the December
22nd issue of Science: Press Release.
- November 2006
Dr. Richard Gracely joins Algynomics and will coordinate the design
and analysis of clinical pain studies.
- October 2006
Scientific founders co-publish a new gene discovery that diminishes pain perception in humans in the October 22nd issue of
Nature Medicine: Press Release.
- October 2006
Algynomics Inc. enters into a first-of-its-kind agreement with Clinical Data Inc. to market and
commercialize proprietary pain genetic markers and test purposes:
Press Release.
- January 2006
Dr. Roger Fillingim joins Algynomics and will coordinate the
development of Pain Diagnostic and Treatment medical devices that integrate genetic tests with neurological and psychological determinants of chronic pain
conditions.
- November 2005
Algynomics Inc. enters into a landmark licensing agreement with the University of North Carolina. The agreement provides Algynomics with the exclusive rights
to develop and market proprietary genetic pain markers owned and patented (pending) by the University of North Carolina.
- August 2005
Algynomics Inc. enlists the services of Mr. David R. LaVance
as General Manager and Director of Business Development.
- May 2005
Algynomics Inc. enlists the legal services of Mr. Bill Wofford and
Hutchinson Law Group.
- March 2005
Algynomics is Incorporated by Scientific Founders Dr. William Maixner and
Dr. Luda Diatchenko.